Fortitude Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Fortitude Advisory Group's ABBV Position: Q3 2026 in Review
Fortitude Advisory Group increased its AbbVie (ABBV) stake by 1.4% in Q3 2026, buying an estimated $20.5K and bringing the position to 5,787 shares worth $1.51M. The position accounts for 0.58% of the portfolio, ranked #31.
Fortitude Advisory Group first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Fortitude Advisory Group held 5,787 shares of AbbVie worth $1.51M as of Q3 2026.
- Fortitude Advisory Group bought 80 AbbVie shares in Q3 2026, an estimated $20.5K.
- AbbVie made up 0.58% of Fortitude Advisory Group's portfolio in Q3 2026, its #31 holding.
- Fortitude Advisory Group first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Fortitude Advisory Group's 13F filing for Q3 2026, filed 15 Oct 2026.